1 Introduction to Research & Analysis Reports
    1.1 Anti-Obesity Prescription Drugs Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Anti-Obesity Prescription Drugs Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Anti-Obesity Prescription Drugs Overall Market Size
    2.1 Global Anti-Obesity Prescription Drugs Market Size: 2021 VS 2027
    2.2 Global Anti-Obesity Prescription Drugs Revenue, Prospects & Forecasts: 2016-2027
    2.3 Global Anti-Obesity Prescription Drugs Sales (Consumption): 2016-2027
3 Company Landscape
    3.1 Top Anti-Obesity Prescription Drugs Players in Global Market
    3.2 Top Global Anti-Obesity Prescription Drugs Companies Ranked by Revenue
    3.3 Global Anti-Obesity Prescription Drugs Revenue by Companies
    3.4 Global Anti-Obesity Prescription Drugs Sales by Companies
    3.5 Global Anti-Obesity Prescription Drugs Price by Manufacturer (2016-2021)
    3.6 Top 3 and Top 5 Anti-Obesity Prescription Drugs Companies in Global Market, by Revenue in 2020
    3.7 Global Manufacturers Anti-Obesity Prescription Drugs Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Anti-Obesity Prescription Drugs Players in Global Market
        3.8.1 List of Global Tier 1 Anti-Obesity Prescription Drugs Companies
        3.8.2 List of Global Tier 2 and Tier 3 Anti-Obesity Prescription Drugs Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Anti-Obesity Prescription Drugs Market Size Markets, 2021 & 2027
        4.1.2 Pediatric
        4.1.3 Adult
    4.2 By Type - Global Anti-Obesity Prescription Drugs Revenue & Forecasts
        4.2.1 By Type - Global Anti-Obesity Prescription Drugs Revenue, 2016-2021
        4.2.2 By Type - Global Anti-Obesity Prescription Drugs Revenue, 2022-2027
        4.2.3 By Type - Global Anti-Obesity Prescription Drugs Revenue Market Share, 2016-2027
    4.3 By Type - Global Anti-Obesity Prescription Drugs Sales & Forecasts
        4.3.1 By Type - Global Anti-Obesity Prescription Drugs Sales, 2016-2021
        4.3.2 By Type - Global Anti-Obesity Prescription Drugs Sales, 2022-2027
        4.3.3 By Type - Global Anti-Obesity Prescription Drugs Sales Market Share, 2016-2027
    4.4 By Type - Global Anti-Obesity Prescription Drugs Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Anti-Obesity Prescription Drugs Market Size, 2021 & 2027
        5.1.2 Hospitals Pharmacies
        5.1.3 Retail Pharmacies
        5.1.4 E-commerce
    5.2 By Application - Global Anti-Obesity Prescription Drugs Revenue & Forecasts
        5.2.1 By Application - Global Anti-Obesity Prescription Drugs Revenue, 2016-2021
        5.2.2 By Application - Global Anti-Obesity Prescription Drugs Revenue, 2022-2027
        5.2.3 By Application - Global Anti-Obesity Prescription Drugs Revenue Market Share, 2016-2027
    5.3 By Application - Global Anti-Obesity Prescription Drugs Sales & Forecasts
        5.3.1 By Application - Global Anti-Obesity Prescription Drugs Sales, 2016-2021
        5.3.2 By Application - Global Anti-Obesity Prescription Drugs Sales, 2022-2027
        5.3.3 By Application - Global Anti-Obesity Prescription Drugs Sales Market Share, 2016-2027
    5.4 By Application - Global Anti-Obesity Prescription Drugs Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
    6.1 By Region - Global Anti-Obesity Prescription Drugs Market Size, 2021 & 2027
    6.2 By Region - Global Anti-Obesity Prescription Drugs Revenue & Forecasts
        6.2.1 By Region - Global Anti-Obesity Prescription Drugs Revenue, 2016-2021
        6.2.2 By Region - Global Anti-Obesity Prescription Drugs Revenue, 2022-2027
        6.2.3 By Region - Global Anti-Obesity Prescription Drugs Revenue Market Share, 2016-2027
    6.3 By Region - Global Anti-Obesity Prescription Drugs Sales & Forecasts
        6.3.1 By Region - Global Anti-Obesity Prescription Drugs Sales, 2016-2021
        6.3.2 By Region - Global Anti-Obesity Prescription Drugs Sales, 2022-2027
        6.3.3 By Region - Global Anti-Obesity Prescription Drugs Sales Market Share, 2016-2027
    6.4 North America
        6.4.1 By Country - North America Anti-Obesity Prescription Drugs Revenue, 2016-2027
        6.4.2 By Country - North America Anti-Obesity Prescription Drugs Sales, 2016-2027
        6.4.3 US Anti-Obesity Prescription Drugs Market Size, 2016-2027
        6.4.4 Canada Anti-Obesity Prescription Drugs Market Size, 2016-2027
        6.4.5 Mexico Anti-Obesity Prescription Drugs Market Size, 2016-2027
    6.5 Europe
        6.5.1 By Country - Europe Anti-Obesity Prescription Drugs Revenue, 2016-2027
        6.5.2 By Country - Europe Anti-Obesity Prescription Drugs Sales, 2016-2027
        6.5.3 Germany Anti-Obesity Prescription Drugs Market Size, 2016-2027
        6.5.4 France Anti-Obesity Prescription Drugs Market Size, 2016-2027
        6.5.5 U.K. Anti-Obesity Prescription Drugs Market Size, 2016-2027
        6.5.6 Italy Anti-Obesity Prescription Drugs Market Size, 2016-2027
        6.5.7 Russia Anti-Obesity Prescription Drugs Market Size, 2016-2027
        6.5.8 Nordic Countries Anti-Obesity Prescription Drugs Market Size, 2016-2027
        6.5.9 Benelux Anti-Obesity Prescription Drugs Market Size, 2016-2027
    6.6 Asia
        6.6.1 By Region - Asia Anti-Obesity Prescription Drugs Revenue, 2016-2027
        6.6.2 By Region - Asia Anti-Obesity Prescription Drugs Sales, 2016-2027
        6.6.3 China Anti-Obesity Prescription Drugs Market Size, 2016-2027
        6.6.4 Japan Anti-Obesity Prescription Drugs Market Size, 2016-2027
        6.6.5 South Korea Anti-Obesity Prescription Drugs Market Size, 2016-2027
        6.6.6 Southeast Asia Anti-Obesity Prescription Drugs Market Size, 2016-2027
        6.6.7 India Anti-Obesity Prescription Drugs Market Size, 2016-2027
    6.7 South America
        6.7.1 By Country - South America Anti-Obesity Prescription Drugs Revenue, 2016-2027
        6.7.2 By Country - South America Anti-Obesity Prescription Drugs Sales, 2016-2027
        6.7.3 Brazil Anti-Obesity Prescription Drugs Market Size, 2016-2027
        6.7.4 Argentina Anti-Obesity Prescription Drugs Market Size, 2016-2027
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Anti-Obesity Prescription Drugs Revenue, 2016-2027
        6.8.2 By Country - Middle East & Africa Anti-Obesity Prescription Drugs Sales, 2016-2027
        6.8.3 Turkey Anti-Obesity Prescription Drugs Market Size, 2016-2027
        6.8.4 Israel Anti-Obesity Prescription Drugs Market Size, 2016-2027
        6.8.5 Saudi Arabia Anti-Obesity Prescription Drugs Market Size, 2016-2027
        6.8.6 UAE Anti-Obesity Prescription Drugs Market Size, 2016-2027
7 Manufacturers & Brands Profiles
    7.1 F Hoffmann La Roche Ltd
        7.1.1 F Hoffmann La Roche Ltd Corporate Summary
        7.1.2 F Hoffmann La Roche Ltd Business Overview
        7.1.3 F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Major Product Offerings
        7.1.4 F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Sales and Revenue in Global (2016-2021)
        7.1.5 F Hoffmann La Roche Ltd Key News
    7.2 Orexigen Therapeutics
        7.2.1 Orexigen Therapeutics Corporate Summary
        7.2.2 Orexigen Therapeutics Business Overview
        7.2.3 Orexigen Therapeutics Anti-Obesity Prescription Drugs Major Product Offerings
        7.2.4 Orexigen Therapeutics Anti-Obesity Prescription Drugs Sales and Revenue in Global (2016-2021)
        7.2.5 Orexigen Therapeutics Key News
    7.3 Novo Nordisk A/s
        7.3.1 Novo Nordisk A/s Corporate Summary
        7.3.2 Novo Nordisk A/s Business Overview
        7.3.3 Novo Nordisk A/s Anti-Obesity Prescription Drugs Major Product Offerings
        7.3.4 Novo Nordisk A/s Anti-Obesity Prescription Drugs Sales and Revenue in Global (2016-2021)
        7.3.5 Novo Nordisk A/s Key News
    7.4 Arena Pharmaceuticals
        7.4.1 Arena Pharmaceuticals Corporate Summary
        7.4.2 Arena Pharmaceuticals Business Overview
        7.4.3 Arena Pharmaceuticals Anti-Obesity Prescription Drugs Major Product Offerings
        7.4.4 Arena Pharmaceuticals Anti-Obesity Prescription Drugs Sales and Revenue in Global (2016-2021)
        7.4.5 Arena Pharmaceuticals Key News
    7.5 Glaxosmithkline
        7.5.1 Glaxosmithkline Corporate Summary
        7.5.2 Glaxosmithkline Business Overview
        7.5.3 Glaxosmithkline Anti-Obesity Prescription Drugs Major Product Offerings
        7.5.4 Glaxosmithkline Anti-Obesity Prescription Drugs Sales and Revenue in Global (2016-2021)
        7.5.5 Glaxosmithkline Key News
    7.6 Vivus
        7.6.1 Vivus Corporate Summary
        7.6.2 Vivus Business Overview
        7.6.3 Vivus Anti-Obesity Prescription Drugs Major Product Offerings
        7.6.4 Vivus Anti-Obesity Prescription Drugs Sales and Revenue in Global (2016-2021)
        7.6.5 Vivus Key News
    7.7 Boehringer Ingelheim
        7.7.1 Boehringer Ingelheim Corporate Summary
        7.7.2 Boehringer Ingelheim Business Overview
        7.7.3 Boehringer Ingelheim Anti-Obesity Prescription Drugs Major Product Offerings
        7.4.4 Boehringer Ingelheim Anti-Obesity Prescription Drugs Sales and Revenue in Global (2016-2021)
        7.7.5 Boehringer Ingelheim Key News
    7.8 Alizyme
        7.8.1 Alizyme Corporate Summary
        7.8.2 Alizyme Business Overview
        7.8.3 Alizyme Anti-Obesity Prescription Drugs Major Product Offerings
        7.8.4 Alizyme Anti-Obesity Prescription Drugs Sales and Revenue in Global (2016-2021)
        7.8.5 Alizyme Key News
8 Global Anti-Obesity Prescription Drugs Production Capacity, Analysis
    8.1 Global Anti-Obesity Prescription Drugs Production Capacity, 2016-2027
    8.2 Anti-Obesity Prescription Drugs Production Capacity of Key Manufacturers in Global Market
    8.3 Global Anti-Obesity Prescription Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Anti-Obesity Prescription Drugs Supply Chain Analysis
    10.1 Anti-Obesity Prescription Drugs Industry Value Chain
    10.2 Anti-Obesity Prescription Drugs Upstream Market
    10.3 Anti-Obesity Prescription Drugs Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Anti-Obesity Prescription Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer